# Protracted Effect of the Ultrasound-guided Saphenous Block

> **NCT02346110** · PHASE4 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 40 (actual)

## Conditions studied

- Arthrosis, Unspecified, Ankle and Foot

## Interventions

- **DRUG:** Bupivacaine-adrenaline
- **DRUG:** Dexamethasone
- **OTHER:** Sodium chloride

## Key facts

- **NCT ID:** NCT02346110
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-12
- **Final completion:** 2016-02
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02346110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02346110, "Protracted Effect of the Ultrasound-guided Saphenous Block". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02346110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*